Filter
1865
Text search:
Cardiovascular
Disease
Featured
Recommendations
184
New Publications
374
Language
Document type
No document type
791
Studies & Reports
467
Guidelines
308
Manuals
86
Strategic & Response Plan
72
Fact sheets
68
Training Material
31
Resource Platforms
12
Dashboards/Maps
8
Infographics
7
Situation Updates
6
Videos
5
Brochures
2
App
1
Online Courses
1
Countries / Regions
Global
157
India
102
Kenya
50
Latin America and the Carribbean
48
Western and Central Europe
41
South Africa
39
Ethiopia
32
Brazil
30
Africa
29
Philippines
27
Ukraine
27
Nigeria
21
Ghana
21
Nepal
19
Tanzania
19
Malawi
19
Syria
18
Namibia
18
Rwanda
17
South–East Asia Region
17
Indonesia
16
Uganda
15
Zambia
15
Myanmar / Burma
15
Bangladesh
14
Colombia
14
Eastern Europe
13
Russia
13
North America
13
Chile
12
Asia
12
Venezuela
12
Sierra Leone
11
Mozambique
11
Eastern Europe and Central Asia
10
Liberia
9
Paraguay
9
Cambodia
8
Eswatini/ Swaziland
8
Botswana
8
Lesotho
8
East and Southern Africa
8
Middle East and North Africa
8
Ecuador
7
USA
6
Germany
6
West and Central Africa
6
Zimbabwe
5
Argentina
5
Peru
5
Bolivia
5
Angola
4
Moldova
4
Vietnam
4
United Kingdom
4
Portugal
4
Haiti
3
Pakistan
3
Iraq
3
Turkey
3
Thailand
3
Papua New Guinea
3
North Macedonia
3
Mexico
3
Yemen
3
Western Pacific Region
3
Albania
3
Laos
3
Kyrgyzstan
3
Spain
3
Guinea
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
Saudi Arabia
2
Cameroon
2
Somalia
2
South Sudan
2
Jordan
2
Afghanistan
2
Lebanon
2
China
2
Sudan
2
Libya
2
Other region
2
Palestine
2
Tajikistan
2
Iran
2
Kazakhstan
2
Jamaica
2
Bosnia and Herzegovina
2
Senegal
1
Egypt
1
Ireland
1
Benin
1
Dominican Republic
1
Switzerland
1
Greece
1
Bahamas
1
Sri Lanka
1
Fiji
1
Bhutan
1
Djibouti
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Georgia
1
Turkmenistan
1
France
1
Mauritius
1
Azerbaijan
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
729
Public Health
273
Clinical Guidelines
198
Women & Child Health
59
Capacity Building
45
Key Resources
42
Pharmacy & Technologies
7
Annual Report MEDBOX
1
Toolboxes
NCDs
292
COVID-19
207
Mental Health
173
Planetary Health
115
HIV
64
Global Health Education
54
Caregiver
45
Pharmacy
43
TB
33
Conflict
32
NTDs
29
Disability
28
Refugee
21
AMR
18
Health Financing Toolbox
16
Rapid Response
12
Natural Hazards
7
Specific Hazards
7
Cholera
5
2.0 Rapid Response
5
Ebola & Marburg
4
Malaria
4
Zika
3
Social Ethics
3
Polio
2
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers fo
...
Aerosol pollutants are known to raise the risk of development of non-communicable respiratory diseases (NCRDs) such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, and allergic rhinitis. Sub-Saharan Africa’s rapid pace of urb
...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious
...
The Atlas of health and climate is a product of this unique collaboration between the meteorological and public health communities. It provides sound scientific information on the connections between weather and climate and major health challenges. These range from diseases of poverty to emergencies
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improv
...
This regional summary draws on the WHO Global oral health status report (2), published in 2022, which provides a comprehensive overview of the global oral disease burden, the global health importance of oral health and the impact of oral diseases ov
...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen
...
This plan, approved by the Organization’s 62nd Directing Council, was shaped by extensive consultations with countries and stakeholders, and commits to transformative health outcomes over the next six years, tackling noncommunicable diseases (NCDs), mental health, health security, fragmented healt
...
Childhood obesity is a major public health problem globally, which could undermine progress towards achieving the Sustainable Development Goals. Prevention is recognized as the most efficient means of curbing the epidemic; however, given the scale of the problem and the many children who need profes
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
State of Health in the WHO African Region
recommended
This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs.
There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50
...
Updated guidance. The guidance provides useful information to staff working in prisons, as well as to health and prison authorities, explaining how to prevent and address a potential outbreak of COVID-19. In addition, it aims to protect the health and well-being of all those who live and work in, an
...
For the primary health worker in a low/middle-income country (LMIC) setting, delivering quality primary care is challenging. This is often complicated by clinical guidance that is out of date, inconsistent and informed by evidence from high-income countries that ignores LMIC resource constraints and
...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat
...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy
...
The protracted humanitarian situation in northeastern Nigeria, particularly in Borno, Adamawa, and Yobe (BAY) States, remains a concern due to ongoing insecurity, displacement, food insecurity, disease outbreaks, and climate-related shocks. To addre
...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C
...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the tre
...
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and accounting, intervention costing and economic analysis, and Phase IV studies. Before new interventions
...